<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font21 { font-size : 21; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">(.%) </span>
   <span class="font30">HIV- </span>
   <span class="font27">patients </span>
   <span class="font21">Roraima </span>
   <span class="font21">ADRM </span>
   <span class="font18">(%) </span>
   <span class="font18">resistance </span>
   <span class="font17">Brazilian </span>
   <span class="font17">HIV </span>
   <span class="font17">sequences </span>
   <span class="font16">subtype </span>
   <span class="font15">viral </span>
   <span class="font15">{border-style </span>
   <span class="font15">AIDS </span>
   <span class="font15">antiretroviral </span>
   <span class="font15">drug </span>
   <span class="font15">px;} </span>
   <span class="font15">#ffffff;} </span>
   <span class="font14">Sciences </span>
   <span class="font14">mutations </span>
   <span class="font14">prevalence </span>
   <span class="font14">study </span>
   <span class="font14">Health </span>
   <span class="font13">(%), </span>
   <span class="font13">Boa </span>
   <span class="font13">plasma </span>
   <span class="font13">ABC, </span>
   <span class="font13">EFV, </span>
   <span class="font13">Pathogens </span>
   <span class="font13">TC, </span>
   <span class="font13">subtypes </span>
   <span class="font13">Biology </span>
   <span class="font13">Brazil. </span>
   <span class="font13">individuals </span>
   <span class="font13">loads </span>
   <span class="font12">ALGC </span>
   <span class="font12">Brazil </span>
   <span class="font12">Life </span>
   <span class="font12">Medicine </span>
   <span class="font12">NRTI </span>
   <span class="font12">[]. </span>
   <span class="font12">copies/ml </span>
   <span class="font12">type </span>
   <span class="font12">FTC, </span>
   <span class="font12">NVP </span>
   <span class="font12">Resistance </span>
   <span class="font12">TDRM </span>
   <span class="font12">Viral </span>
   <span class="font12">described </span>
   <span class="font12">Central </span>
   <span class="font12">HIV: </span>
   <span class="font12">Microbiology </span>
   <span class="font12">NNRTI </span>
   <span class="font12">Northern </span>
   <span class="font12">Res </span>
   <span class="font12">Viruses </span>
   <span class="font12">displayed </span>
   <span class="font12">epidemic </span>
   <span class="font12">low </span>
   <span class="font12">pol </span>
   <span class="font12">px; </span>
   <span class="font12">state </span>
   <span class="font12">strains </span>
   <span class="font12">{font-family </span>
   <span class="font12">ART </span>
   <span class="font12">Antiretroviral </span>
   <span class="font12">DDI </span>
   <span class="font12">Hum </span>
   <span class="font12">KN, </span>
   <span class="font12">Laboratory </span>
   <span class="font12">RPV </span>
   <span class="font12">Retroviruses: </span>
   <span class="font12">font-size </span>
   <span class="font12">load </span>
   <span class="font12">observed </span>
   <span class="font12">undetectable </span>
   <span class="font12">years </span>
   <span class="font11">Brazil: </span>
   <span class="font11">FGN. </span>
   <span class="font11">HIV--infected </span>
   <span class="font11">MV, </span>
   <span class="font11">Microbial </span>
   <span class="font11">Oswaldo </span>
   <span class="font11">Public </span>
   <span class="font11">Roraima. </span>
   <span class="font11">Vista, </span>
   <span class="font11">country </span>
   <span class="font11">data </span>
   <span class="font11">double; </span>
   <span class="font11">failing </span>
   <span class="font11">harbored </span>
   <span class="font11">highly </span>
   <span class="font11">lower </span>
   <span class="font11">phylogenetic </span>
   <span class="font11">rate </span>
   <span class="font11">showed </span>
   <span class="font11">state. </span>
   <span class="font11">studies </span>
   <span class="font11">supported </span>
   <span class="font11">transmitted </span>
   <span class="font11">using </span>
   <span class="font11">(%). </span>
   <span class="font11">(PR/RT) </span>
   <span class="font11">ART-experienced </span>
   <span class="font11">AZT, </span>
   <span class="font11">DDI, </span>
   <span class="font11">ETR, </span>
   <span class="font11">HIV-infected </span>
   <span class="font11">High </span>
   <span class="font11">Venezuela </span>
   <span class="font11">attended </span>
   <span class="font11">blood </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">capital </span>
   <span class="font11">cases </span>
   <span class="font11">cells/μl </span>
   <span class="font11">detected </span>
   <span class="font11">drugs </span>
   <span class="font11">followed </span>
   <span class="font11">high </span>
   <span class="font11">level </span>
   <span class="font11">median </span>
   <span class="font11">molecular </span>
   <span class="font11">obtained </span>
   <span class="font11">patient </span>
   <span class="font11">population </span>
   <span class="font11">reference </span>
   <span class="font11">relatively </span>
   <span class="font11">reverse </span>
   <span class="font11">solid; </span>
   <span class="font11">surveillance </span>
   <span class="font11">therapeutic </span>
   <span class="font11">therapy </span>
   <span class="font11">transcriptase </span>
   <span class="font11">treatment-experienced </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">Brazil, </span>
   <span class="font11">DT, </span>
   <span class="font11">Drug </span>
   <span class="font11">FGN </span>
   <span class="font11">Helena </span>
   <span class="font11">Immunodeficiency </span>
   <span class="font11">Instituto </span>
   <span class="font11">Laboratório </span>
   <span class="font11">Lentivirus </span>
   <span class="font11">Organisms </span>
   <span class="font11">Prevalence </span>
   <span class="font11">Retroviruses </span>
   <span class="font11">Uairén </span>
   <span class="font11">Unknown </span>
   <span class="font11">Vista </span>
   <span class="font11">and/or </span>
   <span class="font11">bold </span>
   <span class="font11">cities </span>
   <span class="font11">classes </span>
   <span class="font11">copies/ml) </span>
   <span class="font11">courier; </span>
   <span class="font11">diversity </span>
   <span class="font11">em; </span>
   <span class="font11">gene </span>
   <span class="font11">genetic </span>
   <span class="font11">higher </span>
   <span class="font11">human </span>
   <span class="font11">immunodeficiency </span>
   <span class="font11">infection </span>
   <span class="font11">information </span>
   <span class="font11">neighboring </span>
   <span class="font11">profile </span>
   <span class="font11">program </span>
   <span class="font11">proportion </span>
   <span class="font11">protease </span>
   <span class="font11">pt;} </span>
   <span class="font11">recombinants </span>
   <span class="font11">reduced </span>
   <span class="font11">state, </span>
   <span class="font11">supporting </span>
   <span class="font11">susceptibility </span>
   <span class="font11">virus </span>
  </p>
 </body>
</html>
